SCHEDULE: Brandes Investment Boosts Stake in Utah Medical Products

Brandes Investment Partners, L.P. and Datum One Series Trust have disclosed a combined beneficial ownership of 14.9% in Utah Medical Products, Inc., signaling a substantial investment position.

Summary

• Brandes Investment Partners, L.P. and Datum One Series Trust have jointly filed a Schedule 13G, indicating their beneficial ownership of Utah Medical Products, Inc. common shares.
• The total beneficial ownership reported is 475,158 shares, representing 14.9% of the class of securities.
• Brandes Investment Partners, L.P. acts as the investment adviser, managing assets for various funds and accounts, including the Brandes Small Cap Value Fund, a series of Datum One Series Trust.
• The filing clarifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.
• Datum One Series Trust, through its Brandes Small Cap Value Fund, holds 218,681 shares, representing 6.9% of the class.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, primarily indicating a significant investment stake without immediate implications for company control or strategy.

Positives

• Significant investment stake by a recognized investment manager (Brandes Investment Partners, L.P.) in Utah Medical Products, Inc.
• The filing indicates a substantial holding of 14.9% of the company's common shares.
• The Brandes Small Cap Value Fund holds a notable 6.9% stake.

Negatives

• The filing is a Schedule 13G, which is an informational filing and does not inherently signal negative news about the company's performance or operations.

Risks

• While not explicitly stated as a risk in this filing, a significant stake by an institutional investor could lead to increased scrutiny or potential pressure on management for strategic changes.
• The filing does not detail specific risks related to Utah Medical Products, Inc.'s business operations or financial health.

Future Outlook

This filing is primarily an ownership disclosure and does not contain forward-looking statements or specific guidance regarding the company's future performance.

Management Comments

• Brandes Investment Partners, L.P. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that significant stake disclosures via Schedule 13G filings are common in the investment management industry, reflecting active portfolio management. This particular filing indicates a substantial interest in Utah Medical Products, Inc. by Brandes Investment Partners, a firm known for its value-oriented investment strategies.

Comparison to Industry Standards

• The filing does not provide performance data or operational metrics that can be directly compared to industry standards or specific competitors.
• The ownership percentage of 14.9% is a significant stake for an institutional investor, often indicating a belief in the company's underlying value or potential.

Stakeholder Impact

• Shareholders may view the increased stake by Brandes Investment Partners as a positive signal of institutional confidence in the company's value.
• Management may face increased expectations for performance and strategic execution due to the significant ownership by an institutional investor.

Next Steps

• Continue to monitor future filings from Brandes Investment Partners, L.P. and Datum One Series Trust for any changes in their ownership stake.
• Observe Utah Medical Products, Inc.'s strategic decisions and performance in light of this significant institutional investment.

Key Dates

Keywords

Utah Medical Products, Brandes Investment Partners, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Shares, Institutional Investor, Datum One Series Trust